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Conclusions. Our results suggest that ANP may decrease peri-Intraperitoneal atrial natriuretic peptide increases peritoneal
toneal fluid absorption (by 51%, partially because of decreasingfluid and solute removal.
the direct lymphatic absorption), resulting in a significant increaseBackground. Atrial natriuretic peptide (ANP) is a hormone
in peritoneal fluid removal and small solute clearances. Whilewith well-known diuretic and vasodilating properties. Recently
the basic diffusive permeability of the peritoneal membraneit was reported that ANP could increase the peritoneal fluid
was not changed, the peritoneal glucose absorption was re-formation and increase peritoneal solute clearance. This study
tarded by adding ANP to peritoneal dialysate, perhaps throughinvestigated the effect of ANP on peritoneal fluid and solute
interaction of ANP with glucose metabolism.transport characteristics.
Methods. Eighteen male Sprague-Dawley rats were divided
into three groups. A four-hour dwell study using 25 mL 2.27%
The daily regimen of four 2 L exchanges that used to beglucose dialysis solution with 50 g/kg ANP (N  6, H-ANP)
or 5 g/kg ANP (N  6, L-ANP) or without ANP (N  8, con- the standard, accepted continuous ambulatory peritoneal
trol) and frequent dialysate and blood sampling was done in dialysis (CAPD) prescription used in the vast majority of
each rat. Radiolabeled human albumin (RISA) was added to patients is now thought to provide inadequate dialysis for
the solution as an intraperitoneal volume marker. some patients, especially large anuric patients [1–4]. HowResults. The intraperitoneal volume was significantly higher
to provide adequate dialysis is one of the major chal-in the H-ANP group as compared with the control group and
lenges to this treatment [5, 6]. Over the past decades,the L-ANP group. The drainage volume was 26.2 1.1, 25.5
0.7, and 29.8  0.8 mL for the control, L-ANP, and H-ANP several pharmacological substances have been used to
groups, respectively (P  0.01). This was related to significant improve the dialysis efficiency of the peritoneum [7–9].
differences in the peritoneal fluid absorption rates (KE; esti- Most of these studies tried to increase the peritoneal
mated as the RISA elimination coefficient): 39  3, 38  3,
solute transport rate, while only a few aimed at increasingand 19  4 L/min, and in the direct lymphatic absorption
the peritoneal ultrafiltration [7, 9]. However, it shouldrate (KEB; estimated as the clearance of RISA from dialysate
be kept in mind that an increase in the peritoneal trans-to blood): 7  1, 6  1, and 4  1 L/min for the control,
L-ANP, and H-ANP groups, respectively (all P  0.01). No port rate also may increase the peritoneal glucose ab-
differences were found in the intraperitoneal volume, KE, and sorption and therefore lower the peritoneal fluid removal
KEB between the control group and the L-ANP group. The [8, 10], which, in turn, may result in decreased clearance
diffusive mass transport coefficient (KBD) for urea, sodium, in spite of the increased peritoneal transport rate [11].potassium, and total protein did not differ among the three
Furthermore, growing evidence suggests that adequategroups. However, the glucose D/D0 was significantly higher,
and the KBD for glucose was significantly lower in the H-ANP fluid balance may play a critical role in peritoneal dialysis
group as compared with the other two groups. Solute clearances [11–16]. Therefore, great efforts should be made to in-
(175% for sodium and 26% for potassium) were signifi- crease both peritoneal fluid and solute removal.
cantly increased in the H-ANP group, mainly as a result of the Atrial natriuretic peptide (ANP) is a vasoactive pep-increased fluid removal in this group.
tide that is involved in the regulation of body fluid bal-
ance [17, 18]. ANP increases the capillary filtration rate
[19] and lowers blood volume [20]. Interestingly, IlebekkKey words: CAPD, adequate dialysis, peritoneal ultrafiltration, fluid
balance, vasoaction, transport, glucose absorption. et al found that an intravenous infusion of ANP could
increase peritoneal fluid formation in pig [21]. More re-Received for publication May 9, 2000
cently, Bianciotti et al found that intravenous use of ANPand in revised form January 8, 2001
Accepted for publication March 2, 2001 (5 g/kg) in nephrectomized rats significantly increased
the peritoneal clearances for small solutes [22]. They also 2001 by the International Society of Nephrology
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found a higher increase in drainage volume after continu- sues, and the volume was recorded. The experimental
study was approved by the Animal Ethical Committeeous exchanges in the ANP group as compared with the
control group, but the reason was not clear [22]. If it of the Karolinska Institute at Huddinge Hospital.
Dialysate samples (0.1 mL) and blood samples (0.1 mLcould be proven that ANP enhances both fluid and solute
removal, it may have clinical applications, as ANP itself of plasma) were analyzed for RISA activity on a Gamma
Counter (Packard Instrument Company, Meriden, CT,is a physiological substance. Another possibility may be
to add ANP to the peritoneal dialysis solutions, but how USA) for 10 minutes each. Dialysate and plasma concen-
trations of urea (urease-glutamate dehydrogenase meth-the use of intraperitoneal ANP would affect peritoneal
transport is still unknown. od), sodium, potassium (ion-selective electrolodes meth-
od), protein (Coomassie Brilliant Blue Dye bindingThe present study investigated the effects of intra-
peritoneal ANP on peritoneal fluid and solute transport method), and glucose concentration (hexokinase method)
were analyzed using a Monarch 1000 autoanalyzer (In-characteristics.
strumentation Laboratory, Lexington, MA, USA).
Intraperitoneal dialysate volume was estimated from
METHODS
the dilution of RISA with corrections made for the elimi-
Twenty male Sprague-Dawley rats with an average nation of RISA from the peritoneal cavity and the sam-
body weight of 300 g were divided into three groups. ple volumes [24]. Note that the intraperitoneal volume
Each rat was anesthetized initially with a single intraperi- at the end of the dwell was measured directly. The perito-
toneal injection of 50 mg/kg pentobarbital sodium. This neal fluid absorption rate was estimated as the coefficient
anesthesia has been reported to not alter peritoneal fluid of RISA elimination from the peritoneal cavity (KE mL/
transport in rats (for example, peritoneal fluid absorption min), and the transcapillary ultrafiltration rate was calcu-
rate and peritoneal lymphatic flow) [23]. After two hours, lated as net volume change plus KE. In separate studies,
the rat was given 25 mg/kg of pure pentobarbital sodium we compared the peritoneal volume with RISA dilution
subcutaneously every hour to maintain the intensity of methods and direct volume measurement, and did not
anesthesia during the experiment. The fur over the ab- find that intraperitoneal ANP significantly altered the
dominal wall was closely shaved. The animal was laid in bulk peritoneal fluid absorption.
a supine position and was kept at 37C with a heating The direct lymphatic absorption of fluid from the peri-
pad (CMA/Microdialysis, Stockholm, Sweden). Isotonic toneal cavity was assessed as the clearance of RISA from
saline (1 mL/h) was injected subcutaneously to prevent the dialysate to the blood (KEB mL/min). KEB was calcu-
hypovolemia. A multiholed silastic catheter (0.8 mm in- lated from the rate of increase of RISA amount in plasma
ternal diameter; Venoflon, Helsingborg, Sweden) was divided by the average intraperitoneal RISA concentra-
inserted percutaneously in the left lower quadrant of the tion [25]. The plasma volume was set at 3.6 mL/100 g
abdomen for dialysis fluid infusion and sampling. Each body weight [25, 26]. The remaining part of the fluid
animal was infused intraperitoneally with 25 mL of Dia- absorption to the peritoneal tissue interstitium and capil-
neal 2.27% glucose dialysis fluid with 50 g/kg ANP laries (KET mL/min) was calculated as KE minus KEB.
(N 6, H-ANP; Sigma, St. Louis, MO, USA) or 5 g/kg The dialysate over plasma concentration ratios (D/P)
ANP (N  6, L-ANP) or without ANP (N  8, control). for all of the investigated solutes were calculated by
The dialysis fluids (with or without ANP) contained dividing the dialysate concentrations of the investigated
18.5 KBq 131I-human serum albumin (RISA; Isopharma solutes at a certain time with the aqueous concentrations
AS, Kjeller, Norway). A priming dose of 0.2 g/L of hu- of the investigated solutes in plasma [27]. If no blood
man serum albumin was added in the dialysis solutions sample was taken at the same time as a dialysate sample,
to minimize the adhesion of tagged albumin to the sur- then the blood concentration of the solute was linearly
face of the catheter. Solutions were prewarmed to 37C interpolated from the blood sample taken before and
before instilled intraperitoneally via a three-way valve after this moment [28]. The D/D0 for glucose was calcu-
(Viggo; Connecta, Helsingborg, Sweden) connected to lated as the dialysate glucose concentration (D) divided
the end of a 0.8 mm catheter over a period of approxi- by the glucose concentration in the fresh dialysis solution
mately one minute and allowed to remain in the perito- (D0). The diffusive mass transport coefficients (KBD mL/
neal cavity for four hours. Dialysate samples (0.35 mL) min) were estimated using the modified Babb-Rander-
were taken at 0, 3, 15, 30, 60, 90, 120, 180, and 240 son-Farrell (BRF) model as described previously [29, 30].
minutes postinfusion. Prior to each sampling, 1 mL of The model describes the net change of the solute amount
the dialysate was flushed back and forth five times in peritoneal dialysate over a time increment equal to
through the catheter. Blood samples were drawn at 0, the rate of solute flow between blood and dialysate due to
120, and 240 minutes from the tail artery. After 240 combined diffusion, convective transport, and peritoneal
minutes, the peritoneal cavity was opened; the dialysate absorption of the solute. In addition, based on previous
studies the sieving coefficients (S) for glucose, urea, so-was collected using syringe and preweighed gauze tis-
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Fig. 1. Intraperitoneal volume versus dwell time. Symbols are: ()
control group (N  8); () low-dose atrial natriuretic peptide (ANP)
group (N 6); () high-dose ANP group (N 6). Data are meansSD.
The intraperitoneal volume was significantly higher in the H-ANP group
as compared to the two other groups (ANOVA repeated measure- Fig. 2. 131I-human serum albumin (RISA) elimination rate from the
ments). peritoneal cavity. Abbreviations are: KE, total RISA elimination rate
representing the fluid absorption rate from the peritoneal cavity; KEB,
RISA elimination rate to the blood from the peritoneal cavity represent-
ing the peritoneal lymphatic absorption; KET, RISA elimination rate to
the peritoneal tissue. Symbols are: () control group; ( ) low-dose
dium, and potassium were set at 0.55 and 0.05 for total ANP group; () high-dose ANP group. *Significant difference between
the two other groups, P  0.01.protein [31, 32]. The clearance of each investigated solute
was calculated as the total amount of the solute in the
drained dialysate at 240 minutes minus the infused
amount and divided by the mean blood concentration the H-ANP group as compared with the L-ANP and the
of the solute and the dwell time. control groups (P 0.01; Fig. 2). However, no significant
differences were found in KE, KEB and KET between theStatistics
L-ANP and the control groups. The transcapillary ultra-
Two-way analysis of variance (ANOVA) with repeated filtration rate (Qu) between 3 and 240 minutes was similarmeasurements and one-way ANOVA were applied to among the three groups: 30.5  2.5, 28.0  2.8, and
compare intraperitoneal volume, KE, KEB, KET, D/P ra- 29.9  6.1 L/min for the control, L-ANP, and H-ANP
tios, and KBD. When ANOVA showed a significant differ- groups, respectively.
ence among the three groups, then Scheffe’s F test was
used to compare the difference between different groups. Transport of solutes
The results are expressed as mean  SD. A P value of The dialysate over concentration ratio (D/D0) of glu-
less than 0.05 was considered significant. cose was significantly higher in the H-ANP group as
compared with the L-ANP and the control groups (P 
0.01), but no significant difference was found betweenRESULTS
the L-ANP and the control groups (Fig. 3). The blood
Fluid transport glucose concentrations at 120 and 240 minutes of the
The intraperitoneal volume was significantly higher in dwell were also significantly higher in the H-ANP group
the high-dose ANP (H-ANP) group as compared with as compared with the other two groups (12.2  2.1,
the low-dose ANP (L-ANP) group and the control group 12.4  1.8, and 25.3  6.1 mmol/L at 240 minutes for
(two-way ANOVA with repeated measurements, P  the control, L-ANP, and H-ANP groups, respectively).
0.01), but there was no significant difference between As a result, there was no significant difference in the
the L-ANP and the control groups (Fig. 1). The drain glucose gradient among the three groups (Fig. 3). The
volume was 26.2  1.1, 25.5  0.7, and 29.8  0.8 mL KBD for glucose was significantly lower in the H-ANP
for the control, L-ANP, and H-ANP groups, respectively group as compared with the other two groups (Table 1).
(P  0.01). The peritoneal fluid absorption rate (esti- There were no significant differences in D/P values or
mated as the RISA elimination coefficient, KE), the lym- KBD values for any of the other investigated solutes among
phatic flow rate as estimated by KEB, and the fluid absorp- the three groups, although the D/P for urea tended to be
lower in the H-ANP group as compared with the othertion to peritoneal tissue, KET, were significantly lower in
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ent [33]. Therefore, it is not surprising that the Qu did
not differ among the groups, as the glucose gradient was
not significantly different among them. On the other
hand, Qu also depends on the membrane hydraulic per-
meability. It is a well-known phenomenon that ANP may
increase fluid removal from the capillary vessels. Some
studies suggested that the increased fluid removal in-
duced by ANP was due to increased capillary filtration
rate [19] or increased capillary hydraulic conductivity
[34], while others did not [35]. It also was suggested that
decreased capillary fluid absorption may be involved in
the increased fluid removal by ANP [35]. The lack of
significant difference in transcapillary ultrafiltration rate
in the present study suggests that the intraperitoneal use
of ANP did not affect the peritoneal capillary filtration
rate, hydraulic conductivity, or ultrafiltration coefficient.
The mechanism for the decreased peritoneal fluid ab-
sorption rate as assessed by the RISA elimination rate
is not clear. It is generally assumed that peritoneal fluid
absorption is a bulk flow, that is, the absorption of RISA
is accompanied by the absorption of fluid [10, 24, 36].
Using direct intraperitoneal fluid measurement (volu-
metric), several studies found that this assumption is
indeed valid in peritoneal dialysis [37, 38]. We also found
that intraperitoneal use of ANP does not change the
validity of the bulk flow assumption. However, the struc-
tural basis for the bulk flow is still under debate. The
role of the mesothelial layer in the peritoneal absorption
has been considered both important [39] and irrelevant
[36]. As the KE represents the disappearance of RISAFig. 3. Dialysate glucose concentration (D) to fresh dialysate glucose
concentration (D0) ratio (A) and glucose concentration gradient (B) from the peritoneal cavity, the significantly decreased
versus dwell time. Symbols are: () control group (N  8); () low- KE values in the H-ANP group in the present studydose atrial natriuretic peptide (ANP) group (N  6); () high-dose
suggest that the peritoneal mesothelial cell layer may beANP group (N  6). The D/D0 for glucose was significantly higher in
the H-ANP group versus the L-ANP and control groups, P  0.01. involved in the process of peritoneal fluid absorption,
Otherwise there were no significant differences between groups. and that this process may be modulated by ANP. ANP
has been shown to decrease the endothelial permeability
by preventing the formation of intercellular gaps caused
by oxidants [40]. Therefore, it is possible that ANP de-two groups (P  0.07, ANOVA with repeated measure-
creases the transport of RISA (together with fluid) toments; Fig. 4). The peritoneal clearances for sodium and
peritoneal tissue through the intercellular junction ofpotassium were significantly higher in the H-ANP group
mesothelial cells.as compared with the other groups (Table 2). No signifi-
The significantly lower direct lymphatic absorptioncant differences between the groups were found in peri-
rate as assessed by KEB is in agreement with previoustoneal clearances for urea and total protein (Table 2).
reports [41, 42]. Atchison and Johnston found that ANP
attenuates lymph flow in a dose-dependent manner in
DISCUSSION an isolated lymph duct preparation [41], and Ohhashi,
Watanable, and Kawai found that ANP inhibits lymphOur results show that the intraperitoneal use of ANP
may significantly increase peritoneal fluid removal and transport through a reduction of spontaneous contrac-
tions and a marked relaxation of lymphatic smooth mus-small solute clearances in peritoneal dialysis in rats.
The significantly increased fluid removal in the high cles in bovine mesenteric lymphatics [42]. One may argue
that ANP may decrease the blood volume, and thus, usingdose ANP group was mainly caused by a significantly
lower peritoneal fluid absorption rate, whereas the peri- the same factor (3.6 mL/100 g) for blood volume calcula-
tion may not be valid for the ANP group. Note that intoneal transcapillary ultrafiltration rate (Qu) remained
unchanged. In peritoneal dialysis, the transcapillary ultra- our study, the blood pressure values did not decrease in
the ANP group. Furthermore, if the blood volume hadfiltration is caused mainly by the osmotic pressure gradi-
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Table 1. Diffusive mass transport coefficients KBD (mL/min)
for glucose, urea, sodium, potassium, and total protein
KBD mL/min
Group N Glucose Urea Sodium Potassium Protein
Control 8 0.330.04 0.220.09 0.250.06 0.160.02 0.0060.002
L-ANP 6 0.310.04 0.210.09 0.240.04 0.180.02 0.0060.001
H-ANP 6 0.210.06a 0.140.09 0.200.07 0.200.06 0.0070.001
Data are mean  SD. Abbreviations are: ANP, atrial natriuretic peptide; L-ANP, low-dose ANP; H-ANP, high-dose ANP.
a P  0.05 compared with the Control and L-ANP groups
Fig. 4. Dialysate-to-plasma concentration ra-
tio (D/P) for urea (A), sodium (B), potassium
(C ), and total protein (D) versus dwell time.
Symbols are: () control group (N  8); ()
low-dose atrial natriuretic peptide (ANP)
group (N  6); () high-dose ANP group
(N  6). Differences between groups did not
reach statistical significance, although the D/P
for urea tended to be lower in the high-dose
ANP group compared with the other two
groups (P 0.07, ANOVA repeated measure-
ments.
Table 2. Peritoneal clearances of urea, sodium, potassium, cell uptake and metabolism of glucose [44, 45]. There-
and total protein
fore, the KBD values for glucose should be considered to
Peritoneal clearance mL/min be apparent values. It has been suggested that ANP may
Group N Urea Sodium Potassium Protein decrease the glucose utilization in some tissues [46]. The
significantly higher plasma glucose concentration in theControl 8 0.0920.018 0.0080.004 0.0830.006 0.0080.002
L-ANP 6 0.0870.025 0.0040.002 0.0830.004 0.0070.001 H-ANP group may also support this view. In addition,
H-ANP 6 0.0880.024 0.0220.003a 0.1040.012a 0.0090.001
ANP was suggested to inhibit the intestinal absorption
Data are mean  SD. Abbreviations are: ANP, atrial natriuretic peptide; of glucose and sodium, possibly through interaction withL-ANP, low-dose ANP; H-ANP, high-dose ANP.
a P  0.05 compared with the control and L-ANP groups the sodium-glucose cotransporter [47]. Further studies
are needed to elucidate the possible role of ANP in
peritoneal glucose absorption and glucose metabolism,
especially during long-term peritoneal dialysis.dropped significantly in the ANP group, the KEB values
The lack of significant differences in D/P values and KBDin the ANP groups should be significantly higher than
values for sodium, potassium, and protein between thethat of the control group.
ANP groups and the control group suggests that theIt was unexpected that peritoneal glucose absorption
basic diffusive permeability of the peritoneal membranewas retarded by the high dose of ANP. The significantly
was not altered by intraperitoneal administration oflower KBD for glucose in the H-ANP group should be
ANP. The significantly higher potassium and sodiuminterpreted with caution. Increasing evidence suggests
clearances in the H-ANP group were totally due to thethat peritoneal glucose absorption may not be a simple
diffusive transport process [43], but that it also may involve significantly higher fluid removal in this group. The reason
Wang et al: ANP and peritoneal transport518
in Textbook of Peritoneal Dialysis, edited by Gokal R, Nolphfor the slightly lower D/P for urea in the H-ANP group
KD, Dordrecht, Kluwer Academic Publishers, 1994, pp 161–232
is unclear. In a previous report, Bianciotti et al found 9. Maher JF, Hirszel P: Learning peritoneal physiology by pharma-
cological manipulation. Perit Dial Int 2:27–30, 1993that intravenous use of ANP significantly increases the
10. Rippe B, Krediet R: Peritoneal physiology-transport of solutes, inperitoneal small solute clearances (multi-exchanges) in
The Textbook of Peritoneal Dialysis, edited by Gokal R, Nolph
nephrectomized rats [22]. In their study, a higher but not K, Dordrecht, Kluwer Academic,1994, pp 69–113
11. Wang T, Heimbu¨rger O, Waniewski J, et al: Time dependencesignificant increase in drainage volume after continuous
of solute removal during a single exchange. Adv Perit Dial 13:23–28,exchanges in the ANP group as compared with the control
1997
group was also found [22]. Although the D/P values were 12. Lameire N, Vanholder R, Van Loo A, et al: Cardiovascular dis-
eases in peritoneal dialysis patients: The size of the problem. Kid-not reported in their study, the significantly higher solute
ney Int 50(Suppl 56):S28–S36, 1996clearance conceivably could be due to high D/P values in
13. Harty J, Gokal R: Does CAPD provide adequate dialysis?
the ANP group. The reason for this difference between Nephrol Dial Transplant 10:1115–1117, 1995
14. Heimbu¨rger O: Residual renal function, peritoneal transport char-the present study and the previous study is not clear;
acteristics and dialysis adequacy in peritoneal dialysis. Kidney Inthowever, differences in the methods, that is, the intraperi-
50(Suppl 56):S47–S55, 1996
toneal use versus intravenous use of ANP and a four-hour 15. Heaf J: CAPD adequacy and dialysis morbidity: Detrimental effect
of a high peritoneal equilibration rate. Ren Fail 17:575–587, 1995single dwell versus multiple exchanges with 30 minutes for
16. Davies SJ, Bryan J, Phillips L, Russel GI: The predictive valueeach dwell, may contribute to the discrepancies in the
of KT/V and peritoneal solute transport in CAPD patients is depen-
results. dent on the type of comorbidity present. Perit Dial Int 16(Suppl
1):S158–S162, 1996In summary, the present study suggests that intraperito-
17. Brenner B, Ballermann M, Gunning M, Zeidel M: Diverseneal administration of ANP may increase peritoneal fluid
biological actions of atrial natriuretic peptide. Physiol Rev 70:665–
removal through decreasing the peritoneal fluid ab- 699, 1990
18. Perico N, Remuzzi G: Edema of the nephrotic syndrome: Thesorption (direct lymphatic absorption as well as absorption
role of the atrial peptide system. Am J Kidney Dis 22:355–366,into peritoneal tissues), resulting in a significant in-
1993
crease in small solute clearances. While the basic diffusive 19. Groban L, Cowley A, Ebert T: Atrial natriuretic peptide aug-
ments forearm capillary filtration in humans. Am J Physiol 259:permeability of the peritoneal membrane did not seem
H258–H263, 1990to be changed, the peritoneal glucose absorption was re-
20. Almeida F, Suzuki M, Maack T: Atrial natriuretic factor increases
tarded by adding ANP to the peritoneal dialysate, perhaps hematocrit and decreases plasma volume in nephrectomized rats.
Life Sci 39:1193–1199, 1989through an interaction of ANP with glucose metabolism.
21. Ilebekk A, Christensen G, Leistad E, Rutlen D: Atrial natri-
uretic factor increases peritoneal fluid formation in the pig. Acta
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